Shay Shemesh, Chief Development & Operations Officer at Nuvectis Pharma, Inc. (NVCT), bought 3,006 shares at $8.07 ($24K) on 2022-08-31, disclosed to the SEC on 2022-09-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.07 | 1,476 | $12K | 49.1% |
| 2 | $8.07 | 1,530 | $12K | 50.9% |
| Total | $8.07 avg | 3,006 | $24K | 100% |
| Filing → |
| NVCT | BUY | 2023-03-17 | $7K | — | Filing → |
| NVCT | BUY | 2022-12-22 | $4K | — | Filing → |
| NVCT | BUY | 2022-11-18 | $2K | — | Filing → |